FLUFIRVITIDE-3 (FREE C-TERMINAL ACID)

Investigational

Details

Stereochemistry	ABSOLUTE
Molecular Formula	C87H133N19O29
Molecular Weight	1909.0968
Optical Activity	UNSPECIFIED
Defined Stereocenters	18 / 18
E/Z Centers	0
Charge	0

SHOW SMILES / InChI

Structure of FLUFIRVITIDE-3 (FREE C-TERMINAL ACID)

Structure Search

SMILES

CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](N)C(C)C)[C@@H](C)O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC3=CC=C(O)C=C3)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(O)=O

InChI

InChIKey=GIKLOXPFVONKJH-PJLATTGVSA-N

InChI=1S/C87H133N19O29/c1-13-44(10)70(105-75(122)52(20-16-17-29-88)95-86(133)71(46(12)108)106-82(129)61(37-68(117)118)101-74(121)54(26-28-66(113)114)94-84(131)69(90)43(8)9)85(132)102-60(36-67(115)116)81(128)97-55(30-40(2)3)77(124)99-58(34-48-38-91-51-19-15-14-18-50(48)51)80(127)104-63(39-107)83(130)98-57(33-47-21-23-49(109)24-22-47)79(126)100-59(35-64(89)110)76(123)92-45(11)72(119)93-53(25-27-65(111)112)73(120)96-56(31-41(4)5)78(125)103-62(87(134)135)32-42(6)7/h14-15,18-19,21-24,38,40-46,52-63,69-71,91,107-109H,13,16-17,20,25-37,39,88,90H2,1-12H3,(H2,89,110)(H,92,123)(H,93,119)(H,94,131)(H,95,133)(H,96,120)(H,97,128)(H,98,130)(H,99,124)(H,100,126)(H,101,121)(H,102,132)(H,103,125)(H,104,127)(H,105,122)(H,106,129)(H,111,112)(H,113,114)(H,115,116)(H,117,118)(H,134,135)/t44-,45-,46+,52-,53-,54-,55-,56-,57-,58-,59-,60-,61-,62-,63-,69-,70-,71-/m0/s1

HIDE SMILES / InChI

Molecular Formula	C87H133N19O29
Molecular Weight	1909.0968
Charge	0
Count

Stereochemistry	ABSOLUTE
Additional Stereochemistry	No
Defined Stereocenters	18 / 18
E/Z Centers	8
Optical Activity	UNSPECIFIED

Approval Year

Substance Class	Chemical Created by `admin` on `Sat Dec 16 05:12:15 GMT 2023` Edited by `admin` on `Sat Dec 16 05:12:15 GMT 2023`
Record UNII	QOG7VHU2LU
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

FLUFIRVITIDE-3 (FREE C-TERMINAL ACID)

Common Name

English

L-LEUCINE, L-VALYL-L-.ALPHA.-GLUTAMYL-L-.ALPHA.-ASPARTYL-L-THREONYL-L-LYSYL-L-ISOLEUCYL-L-.ALPHA.-ASPARTYL-L-LEUCYL-L-TRYPTOPHYL-L-SERYL-L-TYROSYL-L-ASPARAGINYL-L-ALANYL-L-.ALPHA.-GLUTAMYL-L-LEUCYL-

Systematic Name

English

VAL-GLU-ASP-THR-LYS-ILE-ASP-LEU-TRP-SER-TYR-ASN-ALA-GLU-LEU-LEU

Systematic Name

English

Code System Code Type Description

PUBCHEM

134812039

Created by admin on Sat Dec 16 05:12:15 GMT 2023 , Edited by admin on Sat Dec 16 05:12:15 GMT 2023

PRIMARY

FDA UNII

QOG7VHU2LU

Created by admin on Sat Dec 16 05:12:15 GMT 2023 , Edited by admin on Sat Dec 16 05:12:15 GMT 2023

PRIMARY

CAS

156953-42-3

Created by admin on Sat Dec 16 05:12:15 GMT 2023 , Edited by admin on Sat Dec 16 05:12:15 GMT 2023

PRIMARY

Related Record Type Details


					QOG7VHU2LU

FLUFIRVITIDE-3 (FREE C-TERMINAL ACID)

ACTIVE MOIETY

Comments:

Originator: Tulane University School of Medicine; Developer: Autoimmune Technologies; Class: Antiviral, Peptide; Mechanism of Action: HN protein inhibitor; On Fast track: for Influenza virus infections; Highest Development Phase: Phase II for Influenza virus infections; Most Recent Events: 01 Jun 2016 Autoimmune Technologies completes a phase II trial in Healthy volunteers in United Kingdom (NCT02423577), 01 Sep 2015 Phase-II clinical trials in Influenza virus infections (In volunteers) in United Kingdom (Inhalation), 24 Apr 2015 Autoimmune Technologies plans a phase II trial in Healthy volunteers in USA and United Kingdom (NCT02423577)